{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T19:43:00Z","timestamp":1781898180921,"version":"3.54.5"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T00:00:00Z","timestamp":1742601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007109","name":"Universit\u00e0 degli Studi di Ferrara","doi-asserted-by":"publisher","award":["FAR 2022"],"award-info":[{"award-number":["FAR 2022"]}],"id":[{"id":"10.13039\/501100007109","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-94165-0","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T16:46:48Z","timestamp":1742662008000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Viral mediated \u03b1-synuclein overexpression results in greater transgene levels and \u03b1-synuclein overload in mice bearing kinase dead mutation of LRRK2"],"prefix":"10.1038","volume":"15","author":[{"given":"Federica","family":"Albanese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Domenicale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Mercatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Brugnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Dovero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwan","family":"Bezard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Morari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,22]]},"reference":[{"key":"94165_CR1","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.neuron.2004.10.023","volume":"44","author":"C Paisan-Ruiz","year":"2004","unstructured":"Paisan-Ruiz, C. et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson\u2019s disease. Neuron 44, 595\u2013600. https:\/\/doi.org\/10.1016\/j.neuron.2004.10.023 (2004).","journal-title":"Neuron"},{"key":"94165_CR2","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","volume":"44","author":"A Zimprich","year":"2004","unstructured":"Zimprich, A. et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44, 601\u2013607. https:\/\/doi.org\/10.1016\/j.neuron.2004.11.005 (2004).","journal-title":"Neuron"},{"key":"94165_CR3","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/ng.3043","volume":"46","author":"MA Nalls","year":"2014","unstructured":"Nalls, M. A. et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson\u2019s disease. Nat. Genet. 46, 989\u2013993. https:\/\/doi.org\/10.1038\/ng.3043 (2014).","journal-title":"Nat. Genet."},{"key":"94165_CR4","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nrn2935","volume":"11","author":"MR Cookson","year":"2010","unstructured":"Cookson, M. R. The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson\u2019s disease. Nat. Rev. Neurosci. 11, 791\u2013797. https:\/\/doi.org\/10.1038\/nrn2935 (2010).","journal-title":"Nat. Rev. Neurosci."},{"key":"94165_CR5","doi-asserted-by":"publisher","first-page":"16842","DOI":"10.1073\/pnas.0507360102","volume":"102","author":"AB West","year":"2005","unstructured":"West, A. B. et al. Parkinson\u2019s disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc. Natl. Acad. Sci. U. S. A.. 102, 16842\u201316847. https:\/\/doi.org\/10.1073\/pnas.0507360102 (2005).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"94165_CR6","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.nbd.2006.04.001","volume":"23","author":"E Greggio","year":"2006","unstructured":"Greggio, E. et al. Kinase activity is required for the toxic effects of mutant LRRK2\/dardarin. Neurobiol. Dis. 23, 329\u2013341. https:\/\/doi.org\/10.1016\/j.nbd.2006.04.001 (2006).","journal-title":"Neurobiol. Dis."},{"key":"94165_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.nbd.2010.04.002","volume":"40","author":"C Yao","year":"2010","unstructured":"Yao, C. et al. LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a caenorhabditis elegans model of Parkinson\u2019s disease. Neurobiol. Dis. 40, 73\u201381. https:\/\/doi.org\/10.1016\/j.nbd.2010.04.002 (2010).","journal-title":"Neurobiol. Dis."},{"key":"94165_CR8","doi-asserted-by":"publisher","first-page":"NS20220040","DOI":"10.1042\/NS20220040","volume":"7","author":"C Domenicale","year":"2023","unstructured":"Domenicale, C., Magnabosco, S. & Morari, M. Modeling Parkinson\u2019s disease in LRRK2 rodents. Neuronal. Signal. 7, NS20220040. https:\/\/doi.org\/10.1042\/NS20220040 (2023).","journal-title":"Neuronal. Signal."},{"key":"94165_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/978-3-319-49969-7_9","volume":"14","author":"Y Xiong","year":"2017","unstructured":"Xiong, Y., Dawson, T. M. & Dawson, V. L. Models of LRRK2-associated Parkinson\u2019s disease. Adv. Neurobiol. 14, 163\u2013191. https:\/\/doi.org\/10.1007\/978-3-319-49969-7_9 (2017).","journal-title":"Adv. Neurobiol."},{"key":"94165_CR10","doi-asserted-by":"publisher","unstructured":"Xiong, Y. et al. Overexpression of Parkinson\u2019s disease-associated mutation LRRK2 G2019S in mouse forebrain induces behavioral deficits and alpha-synuclein pathology. eNeuro. 4 https:\/\/doi.org\/10.1523\/ENEURO.0004-17.2017 (2017).","DOI":"10.1523\/ENEURO.0004-17.2017"},{"key":"94165_CR11","doi-asserted-by":"publisher","unstructured":"Domenicale, C. et al. Dopamine transporter, PhosphoSerine129 alpha-synuclein and alpha-synuclein levels in aged LRRK2 G2019S knock-in and knock-out mice. Biomedicines. 10 https:\/\/doi.org\/10.3390\/biomedicines10040881 (2022).","DOI":"10.3390\/biomedicines10040881"},{"key":"94165_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.nbd.2018.08.018","volume":"120","author":"S Novello","year":"2018","unstructured":"Novello, S. et al. G2019S LRRK2 mutation facilitates alpha-synuclein neuropathology in aged mice. Neurobiol. Dis. 120, 21\u201333. https:\/\/doi.org\/10.1016\/j.nbd.2018.08.018 (2018).","journal-title":"Neurobiol. Dis."},{"key":"94165_CR13","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.neuron.2009.11.006","volume":"64","author":"X Lin","year":"2009","unstructured":"Lin, X. et al. Leucine-rich repeat kinase 2 regulates the progression of neuropathology induced by Parkinson\u2019s-disease-related mutant alpha-synuclein. Neuron 64, 807\u2013827. https:\/\/doi.org\/10.1016\/j.neuron.2009.11.006 (2009).","journal-title":"Neuron"},{"key":"94165_CR14","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1093\/hmg\/dds057","volume":"21","author":"JP Daher","year":"2012","unstructured":"Daher, J. P. et al. Neurodegenerative phenotypes in an A53T alpha-synuclein Transgenic mouse model are independent of LRRK2. Hum. Mol. Genet. 21, 2420\u20132431. https:\/\/doi.org\/10.1093\/hmg\/dds057 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"94165_CR15","doi-asserted-by":"publisher","first-page":"e36581","DOI":"10.1371\/journal.pone.0036581PONE-D-12-03076","volume":"7","author":"MC Herzig","year":"2012","unstructured":"Herzig, M. C. et al. High LRRK2 levels fail to induce or exacerbate neuronal alpha-synucleinopathy in mouse brain. PLoS One. 7, e36581. https:\/\/doi.org\/10.1371\/journal.pone.0036581PONE-D-12-03076 (2012). [pii].","journal-title":"PLoS One"},{"key":"94165_CR16","doi-asserted-by":"publisher","first-page":"19433","DOI":"10.1074\/jbc.M115.660001","volume":"290","author":"JP Daher","year":"2015","unstructured":"Daher, J. P. et al. Leucine-rich repeat kinase 2 (LRRK2) Pharmacological Inhibition abates alpha-Synuclein Gene-induced neurodegeneration. J. Biol. Chem. 290, 19433\u201319444. https:\/\/doi.org\/10.1074\/jbc.M115.660001 (2015).","journal-title":"J. Biol. Chem."},{"key":"94165_CR17","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s00401-019-01995-0","volume":"137","author":"G Bieri","year":"2019","unstructured":"Bieri, G. et al. LRRK2 modifies alpha-syn pathology and spread in mouse models and human neurons. Acta Neuropathol. 137, 961\u2013980. https:\/\/doi.org\/10.1007\/s00401-019-01995-0 (2019).","journal-title":"Acta Neuropathol."},{"key":"94165_CR18","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1126\/science.1101738","volume":"305","author":"AM Cuervo","year":"2004","unstructured":"Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T. & Sulzer, D. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 305, 1292\u20131295. https:\/\/doi.org\/10.1126\/science.1101738 (2004).","journal-title":"Science"},{"key":"94165_CR19","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.tig.2008.10.002","volume":"24","author":"AM Cuervo","year":"2008","unstructured":"Cuervo, A. M. Autophagy and aging: keeping that old broom working. Trends Genet. 24, 604\u2013612. https:\/\/doi.org\/10.1016\/j.tig.2008.10.002 (2008).","journal-title":"Trends Genet."},{"key":"94165_CR20","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1042\/BST20211288","volume":"50","author":"F Albanese","year":"2022","unstructured":"Albanese, F., Domenicale, C., Volta, M. & Morari, M. Modeling Parkinson\u2019s disease in LRRK2 mice: focus on synaptic dysfunction and the autophagy-lysosomal pathway. Biochem. Soc. Trans. 50, 621\u2013632. https:\/\/doi.org\/10.1042\/BST20211288 (2022).","journal-title":"Biochem. Soc. Trans."},{"key":"94165_CR21","doi-asserted-by":"publisher","first-page":"105487","DOI":"10.1016\/j.nbd.2021.105487","volume":"159","author":"F Albanese","year":"2021","unstructured":"Albanese, F. et al. Constitutive Silencing of LRRK2 kinase activity leads to early glucocerebrosidase deregulation and late impairment of autophagy in vivo. Neurobiol. Dis. 159, 105487. https:\/\/doi.org\/10.1016\/j.nbd.2021.105487 (2021).","journal-title":"Neurobiol. Dis."},{"key":"94165_CR22","doi-asserted-by":"publisher","unstructured":"Albanese, F., Novello, S. & Morari, M. Autophagy and LRRK2 in the aging brain. Front. NeuroSci. 13 https:\/\/doi.org\/10.3389\/fnins.2019.01352 (2019).","DOI":"10.3389\/fnins.2019.01352"},{"key":"94165_CR23","doi-asserted-by":"publisher","first-page":"4209","DOI":"10.1093\/hmg\/ddr348","volume":"20","author":"M Herzig","year":"2011","unstructured":"Herzig, M. et al. (ed, C.) LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice. Hum. Mol. Genet. 20 4209\u20134223 https:\/\/doi.org\/10.1093\/hmg\/ddr348 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"94165_CR24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.nbd.2017.12.005","volume":"111","author":"J Schapansky","year":"2018","unstructured":"Schapansky, J. et al. Familial knockin mutation of LRRK2 causes lysosomal dysfunction and accumulation of endogenous insoluble alpha-synuclein in neurons. Neurobiol. Dis. 111, 26\u201335. https:\/\/doi.org\/10.1016\/j.nbd.2017.12.005 (2018).","journal-title":"Neurobiol. Dis."},{"key":"94165_CR25","doi-asserted-by":"publisher","unstructured":"Singh, F. et al. Pharmacological rescue of impaired mitophagy in Parkinson\u2019s disease-related LRRK2 G2019S knock-in mice. eLife 10 https:\/\/doi.org\/10.7554\/eLife.67604 (2021).","DOI":"10.7554\/eLife.67604"},{"key":"94165_CR26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s40478-015-0222-2","volume":"3","author":"M Bourdenx","year":"2015","unstructured":"Bourdenx, M. et al. Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by alpha-synuclein overexpression. Acta Neuropathol. Commun. 3, 46. https:\/\/doi.org\/10.1186\/s40478-015-0222-2 (2015).","journal-title":"Acta Neuropathol. Commun."},{"key":"94165_CR27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.nbd.2016.01.016","volume":"89","author":"L Arcuri","year":"2016","unstructured":"Arcuri, L. et al. Genetic and Pharmacological evidence that endogenous Nociceptin\/orphanin FQ contributes to dopamine cell loss in Parkinson\u2019s disease. Neurobiol. Dis. 89, 55\u201364. https:\/\/doi.org\/10.1016\/j.nbd.2016.01.016 (2016).","journal-title":"Neurobiol. Dis."},{"key":"94165_CR28","doi-asserted-by":"publisher","first-page":"e06302","DOI":"10.1016\/j.heliyon.2021.e06302","volume":"7","author":"X Sun","year":"2021","unstructured":"Sun, X. et al. Comparison of the expression and toxicity of AAV2\/9 carrying the human A53T alpha-synuclein gene in presence or absence of WPRE. Heliyon 7, e06302. https:\/\/doi.org\/10.1016\/j.heliyon.2021.e06302 (2021).","journal-title":"Heliyon"},{"key":"94165_CR29","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.nbd.2011.12.013","volume":"45","author":"M Decressac","year":"2012","unstructured":"Decressac, M., Mattsson, B., Lundblad, M., Weikop, P. & Bjorklund, A. Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons. Neurobiol. Dis. 45, 939\u2013953. https:\/\/doi.org\/10.1016\/j.nbd.2011.12.013 (2012).","journal-title":"Neurobiol. Dis."},{"key":"94165_CR30","doi-asserted-by":"publisher","first-page":"7415","DOI":"10.1523\/JNEUROSCI.3642-15.2016","volume":"36","author":"LA Volpicelli-Daley","year":"2016","unstructured":"Volpicelli-Daley, L. A. et al. G2019S-LRRK2 expression augments alpha-Synuclein sequestration into inclusions in neurons. J. Neurosci. 36, 7415\u20137427. https:\/\/doi.org\/10.1523\/JNEUROSCI.3642-15.2016 (2016).","journal-title":"J. Neurosci."},{"key":"94165_CR31","doi-asserted-by":"publisher","unstructured":"Giaime, E. et al. Age-dependent dopaminergic neurodegeneration and impairment of the autophagy-lysosomal pathway in LRRK-deficient mice. Neuron. 96, 796\u2013807 e796. https:\/\/doi.org\/10.1016\/j.neuron.2017.09.036 (2017).","DOI":"10.1016\/j.neuron.2017.09.036"},{"key":"94165_CR32","doi-asserted-by":"publisher","unstructured":"Shutinoski, B. et al. Lrrk2 alleles modulate inflammation during microbial infection of mice in a sex-dependent manner. Sci. Transl. Med. 11 https:\/\/doi.org\/10.1126\/scitranslmed.aas9292 (2019).","DOI":"10.1126\/scitranslmed.aas9292"},{"key":"94165_CR33","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/ni.3255","volume":"16","author":"JD Rocha","year":"2015","unstructured":"Rocha, J. D., Schlossmacher, M. G. & Philpott, D. J. LRRK2 and Nod2 promote lysozyme sorting in Paneth cells. Nat. Immunol. 16, 898\u2013900. https:\/\/doi.org\/10.1038\/ni.3255 (2015).","journal-title":"Nat. Immunol."},{"key":"94165_CR34","doi-asserted-by":"publisher","first-page":"e17698","DOI":"10.1371\/journal.pone.0017698","volume":"6","author":"JB Koprich","year":"2011","unstructured":"Koprich, J. B. et al. Progressive neurodegeneration or endogenous compensation in an animal model of Parkinson\u2019s disease produced by decreasing doses of alpha-synuclein. PLoS One. 6, e17698. https:\/\/doi.org\/10.1371\/journal.pone.0017698 (2011).","journal-title":"PLoS One"},{"key":"94165_CR35","doi-asserted-by":"publisher","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","volume":"8","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M. & Altman, D. G. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 8, e1000412. https:\/\/doi.org\/10.1371\/journal.pbio.1000412 (2010).","journal-title":"PLoS Biol."},{"key":"94165_CR36","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.nbd.2014.07.013","volume":"71","author":"F Longo","year":"2014","unstructured":"Longo, F., Russo, I., Shimshek, D. R., Greggio, E. & Morari, M. Genetic and pharmacological evidence that G2019S LRRK2 confers a hyperkinetic phenotype, resistant to motor decline associated with aging. Neurobiol. Dis. 71, 62\u201373. https:\/\/doi.org\/10.1016\/j.nbd.2014.07.013 (2014).","journal-title":"Neurobiol. Dis."},{"key":"94165_CR37","doi-asserted-by":"publisher","unstructured":"Novello, S. et al. In vivo susceptibility to energy failure parkinsonism and LRRK2 kinase activity. Neurobiol. Dis. 105579 https:\/\/doi.org\/10.1016\/j.nbd.2021.105579 (2021).","DOI":"10.1016\/j.nbd.2021.105579"},{"key":"94165_CR38","doi-asserted-by":"publisher","first-page":"e00484","DOI":"10.1002\/prp2.484","volume":"7","author":"D Mercatelli","year":"2019","unstructured":"Mercatelli, D. et al. Leucine-rich repeat kinase 2 (LRRK2) inhibitors differentially modulate glutamate release and Serine935 LRRK2 phosphorylation in striatal and cerebrocortical synaptosomes. Pharmacol. Res. Perspect. 7, e00484. https:\/\/doi.org\/10.1002\/prp2.484 (2019).","journal-title":"Pharmacol. Res. Perspect."},{"key":"94165_CR39","doi-asserted-by":"publisher","first-page":"9591","DOI":"10.1523\/JNEUROSCI.2546-05.2005","volume":"25","author":"M Marti","year":"2005","unstructured":"Marti, M. et al. Blockade of Nociceptin\/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson\u2019s disease. J. Neurosci. 25, 9591\u20139601. https:\/\/doi.org\/10.1523\/JNEUROSCI.2546-05.2005 (2005). 25\/42\/9591 [pii].","journal-title":"J. Neurosci."},{"key":"94165_CR40","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.nbd.2008.02.011","volume":"30","author":"R Viaro","year":"2008","unstructured":"Viaro, R. et al. Nociceptin\/orphanin FQ receptor Blockade attenuates MPTP-induced parkinsonism. Neurobiol. Dis. 30, 430\u2013438. https:\/\/doi.org\/10.1016\/j.nbd.2008.02.011 (2008).","journal-title":"Neurobiol. Dis."},{"key":"94165_CR41","doi-asserted-by":"publisher","unstructured":"Longo, F. et al. Age-dependent dopamine transporter dysfunction and Serine129 phospho-alpha-synuclein overload in G2019S LRRK2 mice. Acta Neuropathol. Commun.. https:\/\/doi.org\/10.1186\/s40478-017-0426-8 (2017).","DOI":"10.1186\/s40478-017-0426-8"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94165-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94165-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94165-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T16:46:51Z","timestamp":1742662011000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94165-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,22]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["94165"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-94165-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,22]]},"assertion":[{"value":"26 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9992"}}